5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2017-09-20
- Lead Sponsor
- PhytoTech Therapeutics, Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03201835
- Locations
- 🇮🇱
Clinical Research Center (CRC)- Souraskey Medical center, Tel Aviv, Israel
Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- PhytoTech Therapeutics, Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT03005119
- Locations
- 🇮🇱
Sheba medical center, Tel Hashomer, Ramat gan, Israel
A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
Phase 2
Completed
- Conditions
- Epilepsy Intractable
- Interventions
- Drug: PLT101
- First Posted Date
- 2016-12-08
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- PhytoTech Therapeutics, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02987114
- Locations
- 🇮🇱
Pediatric Epilepsy department- Souraskey Medical center, Tel Aviv, Israel
© Copyright 2025. All Rights Reserved by MedPath